Sign in

CIK 0001703647

  • Non-accelerated filer
  • Smaller reporting company

Korro Bio, Inc.

Sign in to watch
Ticker
KRRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472324450
Phone
+1 617-468-1999
Business address
60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
Former names
Frequency Therapeutics, Inc.
Open-market buys, last 90 days
$884,752
in 1 filing
Open-market sales, last 90 days
$2,161,962
in 6 filings, $2.2M under 10b5-1 plans

Net −$1,277,210. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-21 Huang Michael Director Grant or award · Stock Option +14,846 14,846
2022-02-22 Loose Christopher R. Chief Scientific Officer Sale −1,069 $3.53 $4K 34,827
2022-02-22 PFREUNDSCHUH PETER P. Chief Financial Officer Sale −1,542 $3.53 $5K 8,927
2022-02-22 LeBel Carl Chief Development Officer Sale −1,069 $3.53 $4K 11,126
2022-02-22 McCubbin Quentin Chief Manufacturing Officer Sale −1,584 $3.53 $6K 22,771
2022-02-22 Arnold Wendy S Chief People Officer Sale −1,326 $3.53 $5K 11,824
2022-02-18 Loose Christopher R. Chief Scientific Officer Sale −974 $3.87 $4K 35,896
2022-02-18 PFREUNDSCHUH PETER P. Chief Financial Officer Sale −1,404 $3.88 $5K 10,469
2022-02-18 LeBel Carl Chief Development Officer Sale −974 $3.87 $4K 12,195
2022-02-18 McCubbin Quentin Chief Manufacturing Officer Sale −1,411 $3.87 $5K 24,355
2022-02-18 Arnold Wendy S Chief People Officer Sale −1,209 $3.87 $5K 13,150
2022-02-17 Lucchino David L. President and CEO Grant or award · Restricted Stock Unit +300,000 300,000
2022-02-17 PFREUNDSCHUH PETER P. Chief Financial Officer Sale −1,296 $4.20 $5K 11,873
2022-02-17 PFREUNDSCHUH PETER P. Chief Financial Officer Grant or award · Restricted Stock Unit +150,000 150,000
2022-02-17 Loose Christopher R. Chief Scientific Officer Sale −900 $4.19 $4K 36,870
2022-02-17 Loose Christopher R. Chief Scientific Officer Grant or award · Restricted Stock Unit +150,000 150,000
2022-02-17 LeBel Carl Chief Development Officer Sale −901 $4.19 $4K 13,169
2022-02-17 LeBel Carl Chief Development Officer Grant or award · Restricted Stock Unit +150,000 150,000
2022-02-17 McCubbin Quentin Chief Manufacturing Officer Sale −1,303 $4.20 $5K 25,766
2022-02-17 McCubbin Quentin Chief Manufacturing Officer Grant or award · Restricted Stock Unit +150,000 150,000

Page 20 of 23 · 441 trades